T1	intervention 22 45	double-hormonal therapy
T4	outcome-Measure 1137 1164	disease-free survival (DFS)
T6	total-participants 1189 1192	101
T7	control 976 979	TMX
T8	control-participants 1237 1239	51
T9	intervention-participants 1263 1265	50
T10	outcome 1400 1416	overall survival
T11	outcome 1551 1565	risk reduction
T12	outcome 1333 1336	DFS
T2	eligibility 660 762	Premenopausal women who had surgically removed breast cancer with histologically confirmed N + and HR+
T3	cv-cont-mean 1341 1345	43.0
T5	cv-cont-sd 1348 1358	3.6 months
T13	iv-cont-mean 1366 1370	49.9
T14	iv-cont-sd 1373 1384	4.22 months
T15	cv-cont-mean 1421 1425	51.1
T17	cv-cont-sd 1428 1438	3.8 months
T16	iv-cont-mean 1446 1450	53.1
T18	iv-cont-sd 1453 1463	4.2 months
